14 JUL 2023 | EU | EMA confirms acceptance of Intas’ MAA for its ustekinemab (Stelara®) biosimilar Intas...
BioBlast w/e 14 Jul 23
read more
14 JUL 2023 | EU | EMA confirms acceptance of Intas’ MAA for its ustekinemab (Stelara®) biosimilar Intas...
PiPCast™ | Expedited Patent Prosecution in Australia and New Zealand
In this PiPCast™, Kate Legge discusses whether a patent inventor must be human or can include artificial intelligence systems in Australia, and look to the future legal developments in this space.
IP waivers alone are nowhere near enough to increase COVID-19 vaccine access for developing countries, but US support...
Background In October 2020, the Australian Government announced a $1.5 billion investment in a Modern Manufacturing...